Josiah Matthews, MD
Anesthesiology · Albany, GANPI 1497717003
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $8,340 of the $12,978 with a category attached, or 64.3%. It is spread thinly across 49 manufacturers, the largest accounting for just 17.2%. Reporting peaked in 2024 at $3,181 and has fallen 52.3% since, to $1,519 in 2025. Among anesthesiology clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 408 payments — averaging $31.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vertiflex, Inc.$2K
- Boston Scientific$1K
- Abbott$1K
- Spinal Simplicity, LLC$1K
- Scilex Pharmaceuticals Inc.$878
- Nevro Corp.$818
- plus $5K from 43 others
What the payments were for
- Travel & lodging$4,63836%
- Food & beverage$8,34064%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,978 in reported general payments places this provider in the 95th percentile of 1,137 anesthesiology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 2,837 | $69,970 |
| BelsomraSuvorexant | 152 | $68,873 |
| UbrelvyUbrogepant | 57 | $65,077 |
| Nurtec OdtRimegepant Sulfate | 24 | $53,375 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 1,555 | $44,633 |
| Buprenorphine | 174 | $44,553 |
| ZtlidoLidocaine | 51 | $43,311 |
| ElyxybCelecoxib | 12 | $37,917 |
| QuviviqDaridorexant Hcl | 65 | $32,658 |
| MounjaroTirzepatide | 25 | $26,625 |
| QuliptaAtogepant | 16 | $23,450 |
| DayvigoLemborexant | 60 | $20,047 |
| OxycontinOxycodone Hcl | 38 | $19,696 |
| MovantikNaloxegol Oxalate | 48 | $19,161 |
| Xtampza ErOxycodone Myristate | 29 | $17,774 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieUbrelvy, Qulipta, Linzess | $743 | $94,40584 claims |
| Scilex Pharmaceuticals Inc.Ztlido, Elyxyb | $878 | $81,22863 claims |
| MerckBelsomra | $73 | $68,873152 claims |
| PfizerNurtec Odt | $165 | $53,37524 claims |
| Idorsia Pharmaceuticals US IncQuviviq | $127 | $32,65865 claims |
| Lilly USA, LLCMounjaro | $314 | $26,62525 claims |
| Eisai Inc.Dayvigo | $282 | $20,04760 claims |
| Redhill Biopharma Inc.Movantik | $18 | $19,16148 claims |
| Collegium Pharmaceutical, Inc.Xtampza Er | $227 | $17,77429 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,137 anesthesiology providers in Georgia.
Other anesthesiology in Albany
- Margaret HoltzMarietta$622K
- Mark HamiltonAtlanta$351K
- Michael AshmoreAtlanta$214K
- Jessica McCabeJohns Creek$62K
- Stephen KushinsLawrenceville$62K
- Uma ShastriAtlanta$35K
- Jessica McCounRome$34K
- Amit PatelLawrenceville$17K
- Melat GebreAtlanta$16K
- Laura DowneyAtlanta$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.